BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Research and development, 2025
- $2.1B
- YoY, 2025
- +27.1%
- 5-year CAGR
- +12.4%
- 10-year CAGR
- +8.9%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $2.1B | +27.1% |
| 2024 | $1.6B | +14.2% |
| 2023 | $1.4B | +6.9% |
| 2022 | $1.3B | +9.9% |
| 2021 | $1.2B | +5.3% |
| 2020 | $1.1B | −2.6% |
| 2019 | $1.2B | +5.5% |
| 2018 | $1.1B | +11.6% |
| 2017 | $997M | +8.4% |
| 2016 | $920M | +5.0% |
| 2015 | $876M | +7.2% |
| 2014 | $817M | −5.1% |
| 2013 | $861M | −2.8% |
| 2012 | $886M | −1.0% |
| 2011 | $895M | −4.7% |
| 2010 | $939M | −9.3% |
| 2009 | $1.0B | +2.9% |
| 2008 | $1.0B | −7.8% |
| 2007 | $1.1B | — |